Entering text into the input field will update the search result below

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2020 Results - Earnings Call Transcript

May 07, 2020 3:31 PM ETBristol-Myers Squibb Company (BMY), BMYMP
SA Transcripts profile picture
SA Transcripts

Bristol-Myers Squibb Company (NYSE:BMY) Q1 2020 Earnings Conference Call May 7, 2020 8:30 AM ET

Company Participants

Tim Power - VP IR

Giovanni Caforio - Chairman and CEO

David Elkins - CFO

Chris Boerner - Chief Commercialization Officer

Nadim Ahmed - President Hematology

Samit Hirawat - Chief Medical Officer & Head of Global Drug Development

Conference Call Participants

Seamus Fernandez - Guggenheim

Terence Flynn - Goldman Sachs

Geoff Meacham - Bank of America

Chris Schott - JPMorgan

Andrew Baum - Citi

Tim Anderson - Wolfe Research

Matt Phipps - William Blair

Steve Scala - Cowen

Dave Risinger - Morgan Stanley


Good day, and welcome to the Bristol-Myers Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Tim Power, Vice President, Investor Relations. Please go ahead.

Tim Power

Thanks Chloe and good morning everyone. Thanks for joining us this morning for our first quarter financial year results. Joining me this morning with prepared remarks are Giovanni Caforio our Chairman and Chief Executive Officer; and David Elkins, our Chief Financial Officer. Also participating in today's call for the Q&A session are Chris Boerner our Chief Commercialization Officer; Nadim Ahmed, President Hematology and Samit Hirawat our Chief Medical Officer and Head of Global Drug Development.

As you'll note we've posted slides to bms.com for you to follow along with David and Giovanni's remarks. Before we get started, I will read our forward-looking statements. During this call we will make statements about the company's future plans and prospects that constitute forward looking statements.

Actual results may differ materially from those indicated by those forward-looking as a result of various important factors including those discussed in the company's SEC filings. These forward looking statements represent our estimates as of today and should not be

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.